| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.01 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |